BioSyent Inc. (TSXV:RX)
Canada
· Delayed Price · Currency is CAD 15.56
-0.14 (-0.89%)
At close: Mar 9, 2026
BioSyent Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 179 | 128 | 108 | 85 | 104 | 101 | Upgrade
|
| Market Cap Growth | 42.93% | 17.76% | 28.05% | -18.50% | 2.59% | 22.26% | Upgrade
|
| Enterprise Value | 156 | 112 | 80 | 58 | 78 | 79 | Upgrade
|
| Last Close Price | 15.56 | 10.78 | 8.87 | 6.60 | 7.74 | 7.41 | Upgrade
|
| PE Ratio | 20.83 | 17.56 | 16.79 | 15.52 | 16.54 | 26.69 | Upgrade
|
| Forward PE | 16.29 | 14.52 | 17.23 | 13.86 | 18.77 | 21.67 | Upgrade
|
| PS Ratio | 4.24 | 3.65 | 3.43 | 3.03 | 3.63 | 4.54 | Upgrade
|
| PB Ratio | 4.48 | 3.65 | 3.12 | 2.54 | 3.29 | 3.78 | Upgrade
|
| P/TBV Ratio | 5.10 | 4.24 | 3.21 | 2.62 | 3.38 | 3.92 | Upgrade
|
| P/FCF Ratio | 22.07 | 14.80 | 21.71 | 17.28 | 22.64 | 14.72 | Upgrade
|
| P/OCF Ratio | 21.98 | 14.74 | 21.45 | 17.11 | 22.23 | 14.69 | Upgrade
|
| EV/Sales Ratio | 3.71 | 3.19 | 2.55 | 2.09 | 2.74 | 3.55 | Upgrade
|
| EV/EBITDA Ratio | 12.91 | 11.64 | 10.54 | 8.03 | 9.26 | 14.78 | Upgrade
|
| EV/EBIT Ratio | 13.72 | 12.17 | 10.76 | 8.36 | 9.58 | 15.77 | Upgrade
|
| EV/FCF Ratio | 19.30 | 12.94 | 16.10 | 11.90 | 17.08 | 11.53 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.11 | 0.16 | 0.19 | 0.18 | 0.31 | Upgrade
|
| Debt / FCF Ratio | 0.11 | 0.12 | 0.24 | 0.28 | 0.34 | 0.25 | Upgrade
|
| Net Debt / Equity Ratio | -0.56 | -0.43 | -0.72 | -0.82 | -0.84 | -0.89 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.88 | -1.55 | -3.27 | -3.76 | -3.15 | -4.45 | Upgrade
|
| Net Debt / FCF Ratio | -2.78 | -1.73 | -5.00 | -5.57 | -5.81 | -3.47 | Upgrade
|
| Asset Turnover | 0.91 | 0.85 | 0.77 | 0.72 | 0.81 | 0.69 | Upgrade
|
| Inventory Turnover | 1.65 | 1.28 | 1.15 | 1.50 | 2.80 | 2.33 | Upgrade
|
| Quick Ratio | 4.18 | 3.49 | 5.36 | 5.63 | 7.49 | 5.33 | Upgrade
|
| Current Ratio | 5.06 | 4.53 | 6.48 | 6.49 | 8.24 | 5.79 | Upgrade
|
| Return on Equity (ROE) | 22.35% | 20.84% | 18.97% | 16.82% | 21.53% | 14.43% | Upgrade
|
| Return on Assets (ROA) | 15.28% | 13.85% | 11.39% | 11.24% | 14.46% | 9.74% | Upgrade
|
| Return on Invested Capital (ROIC) | 46.89% | 45.66% | 71.34% | 93.57% | 156.76% | 84.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 28.00% | 25.50% | 20.80% | 20.10% | 24.80% | 17.70% | Upgrade
|
| Earnings Yield | 4.83% | 5.69% | 5.96% | 6.44% | 6.04% | 3.75% | Upgrade
|
| FCF Yield | 4.53% | 6.76% | 4.61% | 5.79% | 4.42% | 6.79% | Upgrade
|
| Dividend Yield | 1.40% | 1.67% | 1.80% | 0.61% | - | - | Upgrade
|
| Payout Ratio | 25.50% | 28.61% | 29.61% | 8.87% | - | - | Upgrade
|
| Buyback Yield / Dilution | 2.73% | 2.98% | 2.95% | 2.57% | 1.70% | 6.10% | Upgrade
|
| Total Shareholder Return | 4.13% | 4.65% | 4.76% | 3.18% | 1.70% | 6.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.